Adaptive Biotechnologies (ADPT) Non-Current Assets (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Non-Current Assets data on file, last reported at $214.1 million in Q1 2026.

• Quarterly Non-Current Assets fell 15.81% year-over-year to $214.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $870.6 million (down 12.36% YoY) and the FY2025 annual result came in at $212.6 million, down 16.85% from the prior year.
• Non-Current Assets improved to $214.1 million in Q1 2026 per ADPT's latest filing, from $212.6 million in the prior quarter.
• The five-year high for Non-Current Assets was $439.1 million in Q1 2022, with the low at $209.2 million in Q3 2025.
• Average Non-Current Assets over 5 years is $273.1 million, with a median of $254.4 million recorded in 2025.
• The widest YoY moves for Non-Current Assets: up 42.96% in 2022, down 43.44% in 2022.
• Adaptive Biotechnologies' Non-Current Assets stood at $294.5 million in 2022, then fell by 14.78% to $250.9 million in 2023, then climbed by 1.86% to $255.6 million in 2024, then fell by 16.85% to $212.6 million in 2025, then gained by 0.75% to $214.1 million in 2026.
• Business Quant data shows ADPT's Non-Current Assets at $214.1 million in Q1 2026, $212.6 million in Q4 2025, and $209.2 million in Q3 2025.